Grinfeld et al. reported that JAK2 V617F homozygosity or high JAK2 allele burden was typically associated with PV, and myelofibrotic progression occurred more often in this cohort compared to the JAK2-heterozygous group (p = 0.007) [17]. The gene discussed is JAK2; the disease is acquired polycythemia vera.